Evaluating a Digital Platform for COPD Rehabilitation
Validation of a Digital Platform for Functional Respiratory Rehabilitation (ReHub)
NA · Bio-Sensing Solutions S.L. (DyCare) · NCT06252818
This study is testing a digital platform to see how well it helps people with COPD track their exercise and rehabilitation progress.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Bio-Sensing Solutions S.L. (DyCare) (industry) |
| Locations | 1 site (Barcelona) |
| Trial ID | NCT06252818 on ClinicalTrials.gov |
What this trial studies
This study focuses on assessing the satisfaction and usability of the ReHub platform, designed for therapeutic exercise programs aimed at patients with Chronic Obstructive Pulmonary Disease (COPD). Conducted at the Respiratory Rehabilitation Service of Hospital Sant Pau in Barcelona, the study will involve COPD patients who will use the platform to monitor their rehabilitation progress. The methodology includes a single-center approach with evaluations of clinical parameters and functional status before and after the intervention, without a control group.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older diagnosed with COPD (GOLD grade I - IV) who require respiratory rehabilitation.
Not a fit: Patients with cognitive impairments, language barriers, or those lacking access to a mobile device with internet may not benefit from this study.
Why it matters
Potential benefit: If successful, this platform could enhance the rehabilitation experience and outcomes for COPD patients.
How similar studies have performed: While the specific ReHub platform is novel, similar digital rehabilitation approaches have shown promise in improving patient outcomes in other studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with COPD, GOLD grade I - IV * Need of respiratory rehabilitation. * 18 years of age or older. * Explicit willingness to participate in the study. * Diagnosis of COPD (FEV1/FVC \< 70) Exclusion Criteria: * Individuals with cognitive impairment. * Language barriers or illiteracy (inability to read in Spanish). * Lack of access to a mobile device with an internet connection.
Where this trial is running
Barcelona
- Hospital de la Santa Creu i Sant Pau — Barcelona, Spain (RECRUITING)
Study contacts
- Principal investigator: Carme Puy, MD — Pneumologist at Hospital Santa Creu i Sant Pau
- Study coordinator: Carme Puy, MD
- Email: mpuyr@santpau.cat
- Phone: +34935565972
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: COPD